SAR443579
Sanofi,innate
['frida', 'innate pharma', 'sanofi', 'innatepharma']
our partner will present phase 1/2 dose escalation safety and preliminary efficacy of sar'579/iph6101 at the annual meeting friday, june 2, 2023 2:24 pm - 2:36 pm #innatepharma #innateimmunity #sanofi #oncology #nkcellengager #asco23 
#Biotech #Immunotherapy #ImmunoOncology #Cancer #Inflammation #Antibody #Checkpoints